Casimir D Akpovi
Casimir D Akpovi is an expert in Endocrinology at Université d'Abomey-Calavi (Benin). Casimir D Akpovi has authored 18 publications, the most recent in 2024. SLR score: 43 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Public Health - Urology - Nephrology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2015 - 2024
Number : 18
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Hypersensitivity to man-made electromagnetic fields (EHS) correlates with immune responsivity to oxidative stress: a case report. PMID 39108419 — hypersensitivity, arrhythmias, cardiac, stress, physiological, oxidants, pathology, oxidative stress, telecommunications, signs and symptoms, therapeutics | Commun Integr Biol | 2024 | 5 |
| Some Medicinal Plants with Anti-breast Cancer Activity and the Input of Phytotherapy in the Treatment of Breast Cancer OpenAlex W4382795277 — breast neoplasms, phytotherapy, plants, medicinal, therapeutics | European Scientific Journal | 2023 | 0 |
| Phytochemical Screening, Antioxidant Activity, and Acute Toxicity Evaluation of Extract Used in Traditional Medicine. PMID 36968147 — mortality, medicine, traditional, kidney, liver, antioxidants, phytochemicals | J Toxicol | 2023 | 14 |
| Phytochemical Screening, Antioxidant Activity and Safety of <i>Petroselinum crispum</i> (Mill.) AW Hill Apiaceae Leaves Grown in Benin OpenAlex W4315796073 — safety, antioxidants, catechin, phytochemicals | Open Journal of Applied Sciences | 2023 | 5 |
| Molecular and cellular biology of PCSK9: impact on glucose homeostasis. PMID 35723066 — diabetes mellitus, cells, fasting, insulin, homeostasis, cardiovascular diseases, insulin secretion, cell biology, drug delivery systems, therapeutics, drug evaluation, diabetes mellitus, type 2 | J Drug Target | 2022 | 11 |
LeadR Networks
Main global connection map